Deletion of the 5-HT 3A -receptor subunit blunts the induction of cocaine sensitization by Hodge, C. W. et al.
Deletion of the 5-HT3A-receptor subunit blunts the induction of
cocaine sensitization
C. W. Hodge*, A. M. Bratt, and S. P. Kelley
Departments of Psychiatry and Pharmacology, University of North Carolina at Chapel Hill, Chapel
Hill, NC, USA
Abstract
Serotonin (5-HT) receptors are classified into seven groups (5-HT1–7), comprising at least 14
structurally and pharmacologically distinct receptor subtypes. Pharma-cological antagonism of
ionotropic 5-HT3 receptors has been shown to modulate both behavioral and neuro-chemical aspects
of the induction of sensitization to cocaine. It is not known, however, if specific molecular subunits
of the 5-HT3 receptor influence the development of cocaine sensitization. To address this question,
we studied the effects of acute and chronic intermittent cocaine administration in mice with a targeted
deletion of the gene for the 5-HT3A-receptor subunit (5-HT3A −/−). 5-HT3A (−/−) mice showed
blunted induction of cocaine-induced locomotor sensitization as compared with wild-type littermate
controls. 5-HT3A (−/−) mice did not differ from wild-type littermate controls on measures of basal
motor activity or response to acute cocaine treatment. Enhanced locomotor response to saline
injection following cocaine sensitization was observed equally in 5-HT3A (−/−) and wild-type mice
suggesting similar conditioned effects associated with chronic cocaine treatment. These data show
a role for the 5-HT3A-receptor subunit in the induction of behavioral sensitization to cocaine and
suggest that the 5-HT3A molecular subunit modulates neurobehavioral adaptations to cocaine, which
may underlie aspects of addiction.
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Behavioral sensitization to psychostimulants refers to a progressive augmentation of
responding associated following repeated treatment with amphetamine, cocaine or related
drugs (Robinson et al. 1998). The process of sensitization is thought to produce enduring
adaptive changes in brain and behavioral function that may underlie components of drug
addiction (Kalivas et al. 1998; Robinson & Berridge 2000). Thus, behavioral sensitization is
in vivo model in which progressive alterations in drug-induced behavior can be linked to
changes in specific neurobiological systems (Carlezon & Nestler 2002).
In general, psychostimulant sensitization is mediated by a set of integrated brain structures
termed the ‘motive circuit’ (Pierce & Kalivas 1997). This limbic circuitry, which includes the
mesocorticolimbic pathways, is believed to gate and modulate appropriate behavioral
responses to environmental stimuli. Although cocaine sensitization has been linked to a number
of neurotransmitter systems within this pathway such as dopamine, γ-aminobutyric acid
(GABA) and glutamate [recently reviewed by (Steketee 2005)], the precise mechanisms of
drug sensitization remain to be fully characterized.
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Evidence suggests that serotonin systems may play a role in behavioral sensitization to cocaine
(Cunningham et al. 1992). Cocaine-induced motor activity was enhanced by pretreatment with
the serotonin uptake inhibitor fluoxetine (Herges & Taylor 1998). Other studies have shown
that 5-HT3 receptor antagonists reduce cocaine-induced locomotion in the absence of effects
on basal locomotion (Costall et al. 1990; King et al. 1997, 1998; Reith 1990; Svingos &
Hitzemann 1992), and to attenuate hyperlocomotion induced by direct infusion of dopamine
into the nucleus accumbens (NAcb) (Costall et al. 1987). Of particular interest to the present
study, reports have indicated that 5-HT3 antagonists block the development, or induction, of
behavioral sensitization to cocaine (King et al. 1997) but have no effect on expression of
sensitization tested after a period of withdrawal (Szumlinski et al. 2003). Accordingly, 5-
HT3 immunoreactivity is down-regulated in the shell of the NAcb during the induction of
cocaine sensitization but not 2 weeks after withdrawal of cocaine (Ricci et al. 2004). These
data suggest that 5-HT3 receptors may mediate the induction but not expression of cocaine
sensitization.
The 5-HT3 receptor is a ligand-gated ion channel comprising a pentameric cylindrical-shaped
structure surrounding a centrally gated ion channel (Barnes & Sharp 1999; Fletcher & Barnes
1998; Yan et al. 1999). 5-HT3 receptors are known to be expressed in limbic brain regions,
with dense binding found in frontal cortical layers II–III, amygdala, hippocampus and
moderately dense binding found in the NAcb and striatum (Kilpatrick et al. 1996; Morales et
al. 1998). To date, two channel subunits are known, the 5-HT3A subunit (Belelli et al. 1995;
Maricq et al. 1991), shown to be present in the hippocampus, amygdala, cortex and NAcb
(Tecott et al. 1993); and the 5-HT3B subunit (Davies et al. 1999), known to be co-expressed
with the 5-HT3A subunit in the amygdala, caudate and hippocampus in humans. Heteromeric
assemblies of both subunits display physiological properties closely resembling those of
neuronal 5-HT3 channels (Davies et al. 1999). In rats, however, 5-HT3B subunit transcripts are
restricted to peripheral neurons (Morales & Wang 2002), which suggest that rodent neural 5-
HT3 receptors might be 5-HT3A homomeric receptors or heteromeric receptors containing 5-
HT3A subunits combined with subunits other than the 5-HT3B subunit. Indeed, comparison of
electrophysiological properties of rodent neural 5-HT3 receptors has shown the presence of
receptors with both high and low conductances (Hussy et al. 1994; Jones & Surprenant
1994; Yang et al. 1992), which suggests the presence of at least two different 5-HT3 receptor
channels (Fletcher & Barnes 1998).
The role that specific molecular subunits of 5-HT3 receptors play in the temporal development
of cocaine sensitization has not been studied. The following experiments were designed to




5-HT3A receptor (−/−) mice were derived using homologous recombination as described (Zeitz
et al. 2002). F1 hybrid C57BL/6J × 129 heterozygous progeny were backcrossed with C57BL/
6J mice to produce F9 generation congenics. Heterozygotes from the F9 generation were bred
to generate wild-type and 5-HT3A (−/−) mutants used in the present study. Only male mice
were used in the present study. Genotyping was conducted in Dr David Julius’ laboratory at
the University of California, San Francisco as previously described (Hodge et al. 2004; Kelley
et al. 2003; Zeitz et al. 2002). The experimenter conducting behavioral studies was blind to
genotype. 5-HT3A (−/−) and wild-type C57BL/6 littermate control male mice (age, 15–20
weeks; weight, 28–35 g) were used as test subjects for all behavioral studies. All animals were
drug naïve prior to testing, and separate batches of mice were used for each experimental set.
The mice were housed in plastic cages lined with Cell Sorb bedding and provided with food
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(Harlan, Indianapolis, IN, USA) and water ad libitum. The vivarium was maintained on a 12
h light/dark cycle (lights on at 06:00) at a temperature of 22°C. All procedures were carried
out in accordance with the NIH Guide to Care and Use of Laboratory Animals and institutional
guidelines.
Locomotor apparatus
Locomotor activity was measured in Plexiglass chambers (43 cm2) located in sound-
attenuating cubicles equipped with exhaust fans that masked external noise (Med Associates,
Lafayette, IN, USA). Two sets of 16 pulse-modulated infrared photo beams were placed on
opposite walls at 1-inch centers to record X–Y ambulatory movements. Activity chambers
were computer-interfaced (Med Associates) for data sampling at 100-millisecond resolution.
Horizontal distance traveled (cm) was recorded for all sessions.
Locomotor ability and effects of acute cocaine
5-HT3A (−/−) mice (n = 13) and wild-type controls (N = 10) were handled and weighed daily
for 1 week prior to activity testing. Mice were transported from the adjacent vivarium to the
test room and allowed to acclimatize for a period of 30 min prior to all testing sessions.
Spontaneous locomotor activity and habituation to a novel environment was tested during 1-
h sessions on three consecutive days. Subsequently, the effects of acute cocaine [0, 10.0 and
20.0 mg/kg intraperitoneal (i.p.)] were tested in all mice once per week. Cocaine doses were
administered immediately prior to 15-min locomotor test sessions according to a Latin square
randomized dosing design. Sessions were set at 15 min to limit exposure to the test chambers
because other work has shown that 5-HT3 receptors regulate contextual conditioning (Harrell
& Allan 2003), which may influence sensitization (Robinson et al. 1998).
Locomotor effects of chronic intermittent cocaine
The effects of chronic intermittent cocaine were studied in wild-type (n = 7) and 5-HT3A (−/
−) mice (n = 9) mice. All mice initially received four consecutive days of saline treatment and
exposure to the test chambers for 1-h locomotor trials before exposure to cocaine. Cocaine
(10.0 mg/kg i.p.) was administered every other day (e.g. at 48-h intervals) for a total of six
injections and locomotor trials were run immediately following dosing. All cocaine injections
were administered immediately prior to the start of each locomotor session, in the familiar
context of the testing room in close proximity to the locomotor chambers.
Locomotor responses to saline injections pre- and post-cocaine sensitization
Locomotor response to saline injection was tested 2 days following the final cocaine challenge
trial in the wild-type (n = 7) and 5-HT3A (−/−) mice (n = 9) that received repeated intermittent
exposure to cocaine. The data were compared with the fourth saline control injection that
preceded sensitization testing.
Drugs
Cocaine hydrochloride (Sigma-Aldrich, St Louis, MO, USA) was dissolved in 0.9% saline and
administered intraperitoneally in a volume of 0.01 ml/g body weight. Drug solutions were
prepared immediately prior to each administration.
Data presentation and analysis
Data are presented from locomotor trials that tested: (1) spontaneous locomotor behavior and
habituation in a novel environment, (2) acute cocaine treatment, (3) repeated intermittent (every
other day) injections of cocaine to induce sensitization and (4) response to saline injection pre-
and post-development of cocaine sensitization to characterize conditioning effects of drug-
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environment pairings. Horizontal distance traveled (cm) was recorded during 60-min trials for
baseline locomotor testing and 15-min trials after drug administration. Data were analyzed by
two-way repeated measures ANOVA with cocaine (dose or treatment day) and genotype as
factors. Planned post hoc comparisons were conducted using the Tukey test, P < 0.05. All
statistical analyses were conducted with SigmaStat (Systat Software, San Jose, CA, USA).
Results
Locomotor ability and effects of acute cocaine
Mice lacking the 5-HT3A-receptor subunit showed normal spontaneous locomotor activity and
habituation to the open field over 3 days of testing as compared with wild-type littermate
controls (Fig. 1a). A trend toward reduced habituation by the 5-HT3A (−/−) mice was observed
during day 1 of testing but did not result in statistically significant differences between
genotypes. Acute treatment with cocaine (10–20 mg/kg i.p.) after habituation produced a dose-
dependent increase in locomotor activity in all mice (F2,68 = 38.423, P < 0.001) (Fig. 1b). Wild-
type and 5-HT3A (−/−) mice displayed similar levels of locomotor response to acute cocaine
treatment. No effects of genotype (F1,68 = 0.0647, P > 0.05) or genotype × dose interaction
(F2,68 = 0.321, P > 0.05) were found, showing absence of a differential genotypic sensitivity
to the locomotor-stimulating effects of acute cocaine treatment.
Locomotor effects of repeated intermittent cocaine
Figure 2 shows that repeated intermittent treatment with cocaine (10 mg/kg i.p.) resulted in
significantly heightened locomotion over successive days in both wild-type and 5-HT3A (−/−)
mice (F9,126 = 48.8, P < 0.001). A significant genotype × day interaction was observed
(F9,126 = 2.9, P = 0.004) indicating that genotypic differences in locomotor activity depended
on treatment day. Follow-up multiple comparison procedures (Tukey Test) showed that 5-
HT3A (−/−) mice did not differ in response to saline or the first cocaine treatment but showed
diminished cocaine-induced locomotor response to repeated cocaine exposure (Fig. 2; cocaine
trial 2, 4, 5 and 6).
Effects of drug-associated conditioned cues
Figure 3 shows the locomotor response to saline injection during baseline conditions before
cocaine exposure and 2 days following cocaine sensitization for both wild-type and 5-HT3A
(−/−) mice. Basal activity in response to saline injection did not significantly differ between
the groups either when measured pre- or post-cocaine sensitization [group (F1,31 = 2.709, P >
0.05)]. The locomotor response to saline was significantly heightened when measured
following the final period of cocaine sensitization [day (F1,31 = 26.133, P < 0.001)] as compared
with the pre-cocaine baseline. This may suggest an anticipatory or conditioned effect to chronic
cocaine exposure, produced by repeated pairings of cocaine with the specific environmental
cues associated with the location in which the drug was administered. No group × day
interaction was observed (F1,31 = 0.513, P > 0.05), indicating that both wild-type and 5-
HT3A (−/−) mice displayed similar degrees of hyperlocomotion in response to saline when
tested post-cocaine sensitization.
Discussion
Behavioral sensitization to psychostimulant drugs is characterized by a progressive increase
in locomotor behavior following repeated intermittent exposure. This drug effect has been
studied extensively in animals as a model of behavioral and molecular adaptations that underlie
aspects of drug addiction (Carlezon & Nestler 2002; Robinson & Berridge 1993, 2000; Thomas
et al. 2001; Wolf 1998). Sensitization is thought to consist of components of induction and
expression, which are believed to be temporally distinct and regulated by different
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neurochemical and neuroanatomical systems (Pierce & Kalivas 1997; Vanderschuren &
Kalivas 2000). Induction of sensitization refers to the adaptive changes that take place as a
result of first drug exposures. These initial cellular events precede the enduring changes thought
to underlie the expression of sensitization, which occurs after a period of drug withdrawal.
Results of the present study add to growing evidence that implicates serotonin receptor systems
in the process of behavioral sensitization (Cunningham et al. 1992; Parsons & Justice 1993).
In particular, 5-HT3 receptor antagonists have been reported to attenuate locomotor stimulatory
effects of both systemically administered cocaine (Costall et al. 1990; Reith 1990; Svingos &
Hitzemann 1992) and direct infusion of dopamine into the NAcb (Costall et al. 1987). Other
evidence indicates that coadministration of the 5-HT3 antagonist on-dansetron with cocaine
blocks the induction of cocaine sensitization (King et al. 1997). Similarly, 5-HT3
immunoreactivity is downregulated in the shell of the NAcb during the induction of cocaine
sensitization (Ricci et al. 2004), suggesting that initial adaptations to cocaine may involve
activation of 5-HT3 receptors. In the present study, targeted deletion of the 5-HT3A-receptor
subunit gene resulted in diminished locomotor response to repeated intermittent cocaine
exposure in C57BL/6J mice. This effect appeared to be specifically related to blunted induction
of cocaine sensitization in the 5-HT3A (−/−) mice because these mutants displayed similar basal
activity and locomotor response to acute cocaine treatment when compared with wild-type
mice. These results suggest that full induction of cocaine sensitization requires the 5-HT3A-
receptor subunit.
It will be of interest in future studies to examine involvement of 5-HT3A receptors in the
expression of cocaine sensitization to determine if this system also regulates the progressive
adaptations in brain and behavioral function after cocaine exposure. Evidence suggests that 5-
HT3-receptor antagonists can alter expression of cocaine sensitization but the effect may
depend on when the antagonist compounds are administered in relation to cocaine treatment.
For example, injections of the 5-HT3 antagonist, ondansetron on the first 5 days of withdrawal
from intermittent cocaine significantly blocked the expression of sensitization when tested after
7 days of withdrawal in rats (King et al. 1998). Alternatively, in another study, the 5-HT3
antagonists MDL 72222, Y-25130 or ondansetron were administered before each repeated
cocaine treatment (Szumlinski et al. 2003). Consistent with the results of our study in 5-
HT3A (−/−) mice, 5-HT3 antagonists inhibited the progressive locomotor effects of cocaine
during treatment. However, there was no effect of the antagonist treatment when expression
of cocaine sensitization was tested 3 weeks later (Szumlinski et al. 2003). Together these
studies suggest that 5-HT3-mediated neuro-adaptations that occur during withdrawal are
important for expression of behavioral sensitization to cocaine. Whether 5-HT3A receptors
mediate the withdrawal-associated changes remains to be determined.
In general, induction of behavioral sensitization to cocaine is thought to be mediated by cellular
events in the ventral tegmental area (VTA), NAcb, and prefrontal cortex [reviewed by
(Vanderschuren & Kalivas 2000)]. However, as the 5-HT3A-receptor subunit has been found
to predominate in the hippocampus, amygdala, cortex and NAcb (Tecott et al. 1993), loss of
ligand-gated ion channel function in any or all of these limbic structures may have impacted
development of cocaine sensitization in the 5-HT3A (−/−) mice. Further research is needed to
determine if 5-HT3A receptors regulate the induction cocaine sensitization in a brain region-
dependent manner.
One possible mechanism of action to explain the blunted development of cocaine sensitization
following loss of the 5-HT3A-receptor subtype is that 5-HT3 receptors may modulate midbrain
dopamine systems. In vivo microdialysis studies have confirmed that 5-HT3 receptors regulate
extracellular dopamine levels within the NAcb (Imperato & Angelucci 1989), and that agonists
at the 5-HT3 receptor increase (Chen et al. 1991), while antagonists inhibit accumbal dopamine
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release (Carboni et al. 1989). Chronic cocaine treatment increases both dopamine and serotonin
in the NAcb via interactions with and blockade of their transporters (Ritz et al. 1990), increasing
the likelihood that these transmitters interact to modulate behavioral sensitization.
Electrophysio-logical studies have shown that increased synaptic 5-HT inhibits firing of
neurons in the NAcb (Henry et al. 1989). Also, treatment with LY-278584, a drug which
displays high affinity and selectivity for rat and human brain 5-HT3 receptors (Abi-Dargham
et al. 1993; Wong et al. 1989), decreases the activity of dopaminergic neurons in the VTA
(Minabe et al. 1991). Thus, interaction with dopaminergic systems is one potential mechanism
of 5-HT3 receptor modulation of the induction of cocaine sensitization.
Another potential mechanism by which deletion of the 5-HT3A receptor may have blunted
induction of cocaine sensitization is through modulation of glutamate transmission. A variety
of studies implicate ionotropic N-methyl-D-aspartate (NMDA) receptors in the induction of
cocaine sensitization (Druhan & Wilent 1999; Ida et al. 1995; Karler et al. 1989; Li et al.
1999; Pudiak & Bozarth 1993). Recent evidence indicates that repeated cocaine administration
results in a down-regulation of NMDA NR1 and NR2B receptor subunits in striatum, NAcb
and cortical brain regions (Yamaguchi et al. 2002), which is consistent with cocaine-induced
increases in extracellular glutamate in brain regions that regulate sensitization (Kalivas &
Duffy 1998; Smith et al. 1995; Williams & Steketee 2004). Other evidence indicates that 5-
HT3-receptor activation increases neural glutamate release (Ashworth-Preece et al. 1995;
Funahashi et al. 2004). Thus, it is plausible that absence of 5-HT3–mediated glutamate release
may have resulted in blunted cocaine-induced sensitization in the 5-HT3A (−/−) mice in this
study. It would be of interest to determine if blockade of 5-HT3-receptor function, or 5-
HT3A gene deletion, can prevent cocaine-induced increases in glutamate as seen in behavioral
sensitization.
Another factor to consider when interpreting changes in behavioral sensitization is the role of
conditioning that occurs when repeated drug effects are tested in a specific environment. Many
studies have found evidence to suggest that environmental factors associated with drug
exposure can influence behavioral sensitization (Browman et al. 1998; Partridge & Schenk
1999; Robinson et al. 1998). Specifically, groups of animals in which drug treatments are
paired with the test environment express sensitization at a higher level than groups of animals
that receive drug in an environment, which is novel and unassociated with the test conditions
(Robinson et al. 1998). This issue is important to consider in the present study because 5-
HT3 over-expressing mice exhibit enhanced contextual conditioning (Harrell & Allan 2003),
which suggests that 5-HT3A (−/−) mice may have shown blunted sensitization because of
impaired conditioning. This did not appear to be the case, however, because the 5-HT3A (−/−)
mice showed normal habituation to a novel environment and similar levels of drug-conditioned
effects when tested with saline injection post-cocaine sensitization. Moreover, response to
acute cocaine appeared to be equally attenuated in both genotypes after repeated saline
injections (compare the acute response to cocaine in Fig. 1 to that seen in Fig. 2), which is
consistent with evidence showing that locomotor response to cocaine is attenuated as a function
of increasing exposure to the test environment after repeated saline injections (Todtenkopf &
Carlezon 2006). These observations support the hypothesis that 5-HT3A receptor–related
neuroadaptations and not psychological factors, such as conditioning or stress responding to
the drug or environment, formed the basis for the blunted development of cocaine sensitization
in the 5-HT3A (−/−) mouse. This is of particular relevance as our group has previously reported
differences in anxiety-related behaviors in this mouse (Kelley et al. 2003).
Results of this study suggest that the 5-HT3A-receptor subunit is required for the full induction
of cocaine sensitization. This conclusion is based on the observation that mice carrying a null
mutation for the 5-HT3A-receptor gene were less responsive to the progressive increase in
locomotor activity seen following repeated intermittent cocaine treatment. Although targeted
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gene deletion has been used to create numerous null mutant mice that have been used to identify
a variety of gene-behavior relations (Heisler et al. 1998; Hodge et al. 1999; Jones et al.
1998; Kelley et al. 2003; Saarelainen et al. 2003), use of the traditional gene knockout strategy
raises several interpretive concerns including the potential role of developmental compensation
and influence of mouse genetic background (Gerlai 2001). For example, null mice that lack
the α1 subunit of ionotropic GABAA receptors show developmental compensation in other
molecular subunits of the receptor including decreased expression of β2/3 and γ2 subunits and
increased expression of α2 and α3 subunits (Kralic et al. 2002). At present, there is no evidence
available regarding potential compensatory changes in other 5-HT3 molecular subunits in 5-
HT3A (−/−) mice. However, it appears that deletion of the 5-HT3A subunit prevents the
formation of functional 5-HT3 receptors because the 5-HT3 agonist m-Chlorophenylbiguanide
(mCPBG) has no effect on the firing rate of peripheral nociceptors or cultured dorsal root
ganglion neurons obtained from the 5-HT3A (−/−) mice (Zeitz et al. 2002). Whether
compensatory changes or genetic background contributed to the blunted sensitization seen in
the 5-HT3A (−/−) mice in this study remains to be determined; however, converging evidence
from this study and reports cited above (i.e. King et al. 1997; Ricci et al. 2004) are consistent
with the conclusion that 5-HT3 receptors regulate neurobehavioral adaptations to repeated
cocaine.
In summary, 5-HT3A (−/−) mice showed blunted cocaine-induced locomotor sensitization in
the absence of differential motor ability, acute response to cocaine or response to the
environment paired with cocaine. These data suggest that the 5-HT3A-receptor subunit
modulates adaptive changes in behavior that occur following repeated cocaine exposure. The
precise mechanism(s) underlying blunted development of cocaine sensitization found in the 5-
HT3A (−/−) mice requires further study. However, it is apparent that alterations in neural
functioning and not conditioning effects related to repeated cocaine exposure underlie these
differences. The current data support a role for the 5-HT3A-receptor subunit in the induction
of cocaine sensitization and suggest that agents with selectivity for the 5-HT3A-receptor subunit
may hold therapeutic potential in the treatment of psychostimulant abuse.
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Figure 1. Deletion of the 5-HT3A receptor subunit does not affect motor ability or acute locomotor
response to cocaine
(a) Spontaneous locomotor activity and habituation to a novel open field environment measured
over three consecutive days. (b) Locomotor response to acute cocaine (0–20.0 mg/kg i.p.)
measured during 15-min sessions. Data are plotted as mean horizontal distance traveled (cm)
(±SEM), for wild-type (filled circles, n = 10), and 5-HT3A (−/−) mice (open circles, n = 13).
*Significantly different from saline control; †significantly different from cocaine (10.0 mg/
kg), Tukey test (P < 0.05).
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Figure 2. Targeted deletion of the 5-HT3A receptor subunit blunted the development of cocaine
locomotor sensitization in response to chronic intermittent administration of cocaine (10 mg/kg
i.p.)
Data are presented as mean distance traveled (cm) (±SEM), for 15-min locomotor trials in
wild-type (filled circles, n = 7), and 5-HT3A (−/−) mice (open circles, n = 9) across four initial
saline trials (S1–S4) and six intermittent cocaine exposures.
*Significant difference among genotypes at corresponding x-axis point. 1, wild type
significantly different from acute cocaine (trial 1); 2, both genotypes significantly different
from acute cocaine, Tukey test (P < 0.05).
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Figure 3. No genotypic difference when mice were exposed to the drug-paired environment
The locomotor response to saline injection (0.01 ml/g) at baseline, prior to cocaine exposure
(left panel) and 2 days post-cocaine sensitization (right panel) in wild-type (filled bars, n = 7)
and 5-HT3A (−/−) mice (open bars, n = 9). Data are presented as mean distance traveled (cm)
(±SEM), for 15-min locomotor trials. Two-way ANOVA showed an effect of treatment (P <
0.05) but not genotype, with both genotypes showing significantly heightened activity post-
cocaine.* Significantly different from pre-cocaine within genotype, Tukey test (P < 0.05).
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